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Abstract. In Vietnam, Plasmodium falciparum and P. vivax are responsible for most malaria infections, and
P. malariae and P. ovale infections are rarely reported. Nevertheless, species-specific polymerase chain reaction analysis
on 2,303 blood samples collected during a cross-sectional survey conducted in a forest area of central Vietnam identi-
fied 223 (9.7%) P. falciparum, 170 (7.4%) P. vivax, 95 (4.1%) P. malariae, and 19 (0.8%) P. ovale mono-infections and
164 (7.1%) mixed infections. Of the 671 Plasmodium-positive samples by polymerase chain reaction, only 331 were
detected by microscopy. Microscopy poorly diagnosed P. malariae, P. ovale, and mixed infections. Clinical and sub-
clinical infections occurred in all age groups. The risk for infection and disease decreased with age, probably because
of acquired partial immunity. The common occurrence of sub-patent infections seems to indicate that the malaria burden
is underestimated and that diagnostic and therapeutic policies should be adapted accordingly.
INTRODUCTION
Since the 1990s, the malaria burden in Vietnam has been
efficiently reduced (> 90%) by the national malaria control
program and malaria is now confined to the remote and forest
areas populated mainly by poor ethnic minorities in which a
large proportions (£ 80%) of asymptomatic and untreated
infections with low parasite densities can be found.1,2 Plasmo-
dium falciparum and P. vivax are the most commonly identi-
fied malaria species, with a few rare reports of P. malariae and
P. ovale infections.1,3,4 Nevertheless, routine detection and
management of malaria is based on microscopy (thick blood
film) that has a limited sensitivity (±50 parasites/mL of blood).
Consequently, low-density infections and mixed infections may
be missed. Sub-patent malaria infections, detectable only by
molecular techniques (polymerase chain reaction [PCR]), can
be relatively common in areas of low malaria endemicity in
Southeast Asia and South America and may substantially con-
tribute to maintaining malaria transmission in these areas.5–10
Because Vietnam has reached a pre-elimination stage, with
malaria having been eliminated in most of its territory, further
successes and ultimately elimination require more sensitive
diagnostic tools that are able to successfully detect residual foci
of low transmission for better targeting of control/elimination
efforts. However, because PCR-based diagnosis is limited by
its cost, the need of specific equipment, and trained personnel,
malaria cases reported by the national health information sys-
tem are almost exclusively based on microscopy identification.
To assess more precisely the burden and complexity of human
malaria infections in central Vietnam, we retrospectively ana-
lyzed by PCR blood samples collected in a large cross-sectional
survey conducted within the framework of a project evaluating
the effectiveness of insecticide-treated hammocks.
MATERIALS ANDMETHODS
Sample collection. Filter paper blood samples collected dur-
ing a large-scale malariometric survey conducted in November–
December 2004 in a rural area of central Vietnam (Ninh
Thuan Province) were retrospectively selected to be analyzed
by species-specific PCR. Details on the survey methods and
study site have been reported.1 In brief, the study population
was composed mainly of persons of the Ra-glai ethnic minor-
ity, whose subsistence is based on forest farming and products
exploitation.11 Malaria transmission is low and perennial in
the study region, with two annual peaks (at the beginning and
end of the rainy season), and is mainly caused by Anopheles
dirus sensu stricto, a sylvatic species and an efficient malaria
vector with exophagic and exophilic behavior.
The survey was conducted in the framework of a community-
based cluster randomized trial on the effectiveness of long-
lasting insecticide-treated hammocks in 20 clusters of
approximately 1,000 persons each. The survey, which was
part of the baseline study and was conducted just before
implementation of the intervention, involved 4,090 persons
randomly selected from the study population. After an inter-
view and clinical examination, survey participants provided
a finger prick blood sample for microscopy (thick and thin
blood films) and for molecular and serologic tests. Blood
samples were placed on Whatman grade 3 filter paper
(Whatman, Springfield Mill, United Kingdom). After drying,
filter paper blood samples were kept individually in plastic
bags with silica gel and stored at room temperature in a dark
and dry place.
Protocols and results of microscopic examination of blood
smears have been reported.1 Slide reading and quality control
(double reading) was performed by senior technicians at the
National Institute for Malariology, Parasitology and Ento-
mology (Hanoi, Vietnam). Unfortunately, for the present
study, blood smears were not available for external quality
control (post-PCR). Therefore, microscopy results are those
reported originally.
Sample size. The previously determined parasite rate by
microscopy in the survey was estimated to be 17.7% with a
precision of 4.5%.1 Thus, taking the lower limit of the con-
fidence interval (CI) (13%) as a minimum prevalence by
cluster, a minimum of 100 filter paper blood samples per
cluster (plus a safety margin of 10%) would enable detecting
a minimum parasite rate by PCR of 13% with a 6% precision
at a 95% confidence level. A total of 2,303 filter paper blood
samples were analyzed by species-specific PCR.
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Species-specific semi-nested multiplex PCR. DNA was
extracted from filter paper by using the saponine-chelex
method, and the PCR was performed according to a described
method with primers specific for the 18S rDNA region.12,13
The PCR products were subjected to electrophoresis on a 2%
agarose gel for 60 minutes at 5V/cm with 0.5 + Tris-acetate
EDTA buffer. The gels were stained with ethidium bromide,
and visualized with ultraviolet light. The sizes of the PCR
products were compared with a standard 100-basepair DNA
ladder (Fermentas, Burlington, Ontario, Canada) and posi-
tive controls of each Plasmodium species. Precautions for
cross-contamination during handling were taken by imple-
menting negative controls in each step from extraction to
the nested PCR step. Approximately 5% (n = 120) of the
samples were repeated blindly and results were confirmed by
a senior technician.
The following case definitions were used. Sub-patent
malaria infections were defined as malaria infections detected
by PCR but negative by microscopy (absence of trophozoites
and gametocytes after examining 1,000 leukocytes. Asymp-
tomatic malaria infections were defined as PCR-detected
malaria infections (regardless of microscopy results) without
fever at the time of sampling (body temperature < 37.5°C) or
history of fever during the 3 days before sampling. Symptom-
atic malaria infections were defined as PCR-detected malaria
infections (regardless of microscopic results) with fever at the
time of sampling and/or history of fever during the 3 days
before sampling). A microscopically positive slide was
defined as any slide with either asexual or sexual Plasmodium
stages, or both. For the purpose of our study, inclusion of
gametocytes among positive slides was justified by the need
of having the microscopy comparable to PCR because PCR
detects asexual and sexual stages. Parasite density was defined
as the density of the predominant species in each infection.
Gametocyte prevalence was defined as the prevalence of
malaria infections (detected by PCR) carrying gametocytes
(identified by microscopy) of any of the four species.
Data analysis. Data were entered into Excel (Microsoft,
Redmond, WA) and analyzed by using Stata version 10 soft-
ware (StataCorp LP, College Station, TX). Descriptive statis-
tics were used to compute malariometric indices, and a survey
c2 test (svytab command in STATA) was used to test for
significant differences in proportions (P < 0.05). The preva-
lence of all malaria infections (all PCR-detected infections),
patent/sub-patent, symptomatic/asymptomatic infections, and
gametocyte carriage were computed by age group. The effect
of age on the risk for malaria infection was adjusted for
previously defined confounders such as forest work, bed net
use, and socioeconomic status in a multivariate survey logistic
regression (svylogit command in STATA) to take into
account the cluster design.14 Subsequently, among all malaria
infected cases, the risk for patent infection (compared with
sub-patent infection), the risk of symptomatic infection (com-
pared with asymptomatic infection), the risk of infections
with gametocytes (compared with those without gameto-
cytes), and the risk of mixed infections (compared with
mono-infections) were similarly examined by age groups and
adjusted for the above mentioned confounders in four survey
logistic regression models.
Ethical considerations. The protocol of the cluster random-
ized trial was approved by the Institutional Review Board of
the Institute of Tropical Medicine and by the Ethical Com-
mittee of the University Hospital (both in Antwerp, Belgium).
In Vietnam, the protocol was approved by the National Insti-
tute of Malariology, Parasitology and Entomology (Hanoi)
and the Ministry of Health.1
RESULTS
Malaria species distribution and prevalence. Among 2,303
filter paper blood samples analyzed, 671 were positive by
PCR, resulting in an overall parasite prevalence of 29.1%
(95% CI = 23.3–35.8). Most patients had a Plasmodium
falciparum mono-infection (prevalence = 9.7%), followed by
P. vivax (7.4%), P. malariae (4.1%), and P. ovale (0.8%)
mono-infections (Table 1). Approximately 25% of all infec-
tions yielded more than one Plasmodium species (preva-
lence of mixed infections = 7.1%); £ 3 species could be
identified in 16% of the mixed infections. Co-infections with
P. malariae were the most common (66.5%), followed by
those including P. vivax or P. falciparum. Interestingly,
P. ovale was found in 30.5% (50 of 164) of all mixed infec-
tions. The overall prevalence of P. ovale was high (3%, 69 of
2,303), and this species was mostly observed in mixed infec-
tions (72%, 50 of 69 of the cases). This trend was shared by
P. malariae, which also occurred in 53% of the cases (109 of
204) in co-infections, and P. falciparum and P. vivax prefer-
entially occurred as mono-infections (70%, 223 of 319 and
63%, 170 of 269, respectively).
Among the 671 samples positive by PCR, only in 331
(49%) was the malaria infection also detected by micros-
copy, suggesting that sub-patent malaria infections (14.8%,
340 of 2,303) were as least as prevalent as patent infections
(14.4%) in this population. The microscopically determined
species distribution showed a majority of P. falciparum
mono-infections (n = 149) followed by P. vivax (n = 125);
only two P. malariae and no P. ovale infections were iden-
tified. The prevalence of microscopically detected mixed
infections was only 2.4% (n = 55), all of them P. vivax
co-infections, mostly with P. falciparum (n = 50).
Table 1
Malariometric indices based on PCR and microscopy detection,
central Vietnam*
Malaria indices (n = 2,303) PCR, no. (%) Microscopy,† no. (%)
Overall malaria prevalence 671 (29.1) 331 (14.4)
Mono-infections:mixed
infections (%)
507:164 (3.1) 276:55 (5.0)
Malaria prevalence by species
P. falciparum 223 (9.7) 149 (6.5)
P. vivax 170 (7.4) 125 (5.4)
P. malariae 95 (4.1) 2 (0.1)
P. ovale 19 (0.8) 0
Mixed 164 (7.1) 55 (2.4)
P. malariae 109 (66.5) 5 (9.10)
P. vivax 99 (60.4) 55 (100.0)
P. falciparum 96 (58.5) 50 (90.9)
P. ovale 50 (30.5) 0
Prevalence of gametocytes‡ – 144 (6.3)
Prevalence of sub-patent
infections
340 (14.7) –
Prevalence of asymptomatic
infections
547 (23.8) 265 (11.5)
*PCR = polymerase chain reaction.
†Microscopy examination results of the 671 PCR-positive samples (all PCR-negative
samples were considered negative for microscopy for the purpose of this report).
‡Microscopically detected gametocytes.
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Discrepancies between results of microscopy and PCR were
common. However, because blood smears were not available
for an independent external re-examination, individual compar-
isons between microscopy and molecular results would be spu-
rious. Therefore, the main characteristics of discrepant results
were analyzed after grouping PCR results by mono-infections
or mixed infections. Among PCR-identified P. malariae and
P. ovale mono-infections (n = 114), only 28% (n = 32) were
detected by microscopy but most of them were identified as
P. falciparum or P. vivax mono-infections with a median para-
site density of 56 parasites/mL (interquartile range [IQR] = 12–
320 parasites/mL). Among PCR-identified P. falciparum and
P. vivax mono-infections, 48% (187 of 393) were detected by
microscopy and most (87%, 144 of 187) were identified as
P. falciparum and P. vivaxmono-infections, with a median par-
asite density of 160 parasites/mL (IQR = 40–960 parasites/mL).
Of the 164 mixed infections, 68% (112 of 164) were positive
bymicroscopy,butonly23%(25of112)were identifiedasmixed
infections; the remaining were classified as P. falciparum or
P. vivaxmono-infections. The median parasite density in mixed
infections correctly identified as such by microscopy and PCR
was 240/mL (IQR = 144–760 parasites/mL). Among those clas-
sified as either P. falciparum or P. vivax mono-infections,
the median parasite density was lower (68 parasites/mL, IQR =
24–480 parasites/mL). Among PCR-negative samples, 82 (5%)
were positive by microscopy, most of them either P. falciparum
or P. vivax mono-infections and with a low parasite density
(median density = 32 parasites/mL, IQR = 16–72 parasites/mL).
Because slides results could not be cross-checked, for the pur-
pose of the present analysis, these infections were considered as
false-positives results, although the presence of an infection
cannot be excluded with certainty because PCR analysis may
have failed because of the presence of inhibitors, sample degra-
dation, mutations at primer sites, or errors during handling.
Age-dependent risk for malaria infection and symptoms.
The prevalence of all PCR-detected malaria infections
decreased from 32.5% in the group less than five years of age
to 26.2% in adults ³ 30 years of age, with a slow but signifi-
cantly decreasing trend (P < 0.005, by score test for trend)
(Figure 1). Interestingly, the prevalence of patent infections
across age groups was reduced by more than 60% (from
22.5% to 9.4%), and the prevalence of sub-patent infections
increased by 69% (from 10% to 16.9%). This finding is illus-
trated by the evolution of the sub-patent:patent infections
ratio, which was 0.4 in persons less than five years of age,
approximately 0.8 in persons £ 19 years of aged, and approx-
imately 2 in adults.
Multivariate adjusted analysis for the risk of malaria infec-
tion (all PCR positive) (Table 2) by age group showed that
the decreasing trend in the likelihood of malaria infection
became significant from the age of 20 years with an odds of
infections that was 35% lower in adults compared with chil-
dren less than five years of age (adjusted odds ratio [AOR] =
0.65, 95% CI = 0.46–0.92). Similarly, compared with sub-
patent infections, the likelihood of patent infections (Table 2)
decreased with age although not significantly until the age of
19 years (AOR = 0.38, 95% CI = 0.12–1.18), but significantly
from in those ³ 20 years of age; adults were > 80% less at risk
compared with persons less than five years of age (AOR = 0.18,
95% CI = 0.06–0.43).
The marked decrease in age-specific prevalence of patent
infections correlated with a similar decrease (77%) in the
prevalence of gametocytes from 13.9% to 3.1% (Figure 2).
In the multivariate adjusted model (Table 2), the odds of
carrying gametocytes among infected persons was also > 80%
lower in the adult groups (³ 20 years of age) compared with
children less than five years of age. Interestingly, the preva-
lence of mixed infections also decreased with age (from 10.1%
to 5.2%), and the prevalence of mono-infections did not
decrease. In the multivariate adjusted model (Table 2) infec-
ted adults (> 30 years old) were 66% less at risk of having a
mixed infection (compared with a mono-infection) compared
with infected children less than five years of age. The age-
related decrease of all microscopically defined indices (patent,
mixed species, and gametocyte carrying infections) correlated
well with a significant reduction (more than 10-fold) of the
mean parasite density (geometric mean), which decreased
from 883 parasites/mL (95% CI = 518–1,519) in persons less
than five years of age to 61 parasites/mL (95% CI = 42–88) in
adults ³ 30 years of age (Figure 2).
Most (81.5) malaria infections detected by PCR were
asymptomatic at the time of the survey, and the proportion
of symptomatic infections was similar between sub-patent
and patent infections, i.e., 17.1% (58 of 340) and 19.9%
Figure 1. Prevalence of patent (gray bars) and sub-patent (white bars) malaria infections by age group, Central Vietnam.
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(66 of 331), respectively. The prevalence of symptomatic
infections decreased progressively, from 9.1% persons less
than five years of age to 3.5% in adults, and the prevalence
of asymptomatic infections remained stable at approxi-
mately 23% (Figure 3). The evolution of symptomatic infec-
tions with age mirrored the evolution of sub-patent infections.
There was an overall decreasing trend with age in the propor-
tion of symptomatic infections, i.e., from 28% in children less
than five years of age to 12% in adults ³ 30 years of age,
similarly in sub-patent and patent infections.
The multivariate adjusted risk of symptomatic infection
among infected persons (Table 2E) decreased by 63% in young
adults (20–29 years of age;AOR= 0.37, 95%CI= 0.17–0.81) and
by almost 75% in adults (³ 30 years of age) compared with
children less than five years of age.
DISCUSSION
In Vietnam, the malaria control program has success-
fully relied on microscopic diagnosis to reduce the burden of
malaria. As previously reported, in the remaining malaria-
endemic areas located mainly in central Vietnam, asymptom-
atic infections are common.1 Our analysis by PCR showed a
higher prevalence and more complex species distribution than
expected by routine microscopy. Half of the infections detected
by PCR were sub-patent, suggesting that the actual occurrence
of malaria exceeds that usually estimated by microscopy. This
finding was reported in a meta-analysis by Okell and others in
2009, which showed that the prevalence of P. falciparum infec-
tions by microscopy was on average 50% of that measured by
PCR and that this difference was increasing with decreasing
transmission.15 More precisely, the median parasite prevalence
by PCR was 35.7% (IQR = 24.9–48.5) for areas where micro-
scopic prevalence is 10.0–24.9%, which is consistent with our
results, i.e., 29.1% and 14.4%, respectively.
More interestingly, P. malariae and P. ovale were not rare
species, as detected by standard microscopy, and often
occurred in mixed infections, which were commonly observed
by PCR in our population. These findings confirm previous
reports from other countries in Southeast Asia and Africa,
where use of molecular techniques showed a high complexity
of infections, i.e., high proportions of mixed infections and
high occurrence of P. malariae and P. ovale compared with
that detected by standard microscopy.7,8,16–18
Presumably, low parasite densities made it difficult to accu-
rately identify the Plasmodium infection and to detect cryptic
species by microscopy. This suggestion is supported by the
higher parasite densities for the mixed infection identified
by both techniques, and the constantly higher frequency of
P. falciparum or P. vivax mono-infections identified at low-
level densities. Because P. malariae and P. ovale have so far
been considered rare species, technicians are more likely
to recall the well-known P. falciparum and P. vivax mono-
infections. In cases of low parasite counts, the higher sensitivity
and specificity of PCR over microscopy lead to more accurate
species identification.7,8,16
Because PCR cannot be routinely used for diagnosis,
awareness of the species distribution and further training on
the detection of non-falciparum malaria could improve con-
trol efforts. This information is particularly important for
P. vivax and P. ovale, for which dormant liver forms can be
reactivated months or years after the primary infection, but
also for P. malariae, which has been reported to cause malaria
attack years after the primary infection.19
The high proportion of asymptomatic and sub-patent
infections indicates the development of partial immunity that
is able to control parasitemia and maintain it at low and even
undetectable densities.5,20 The degree of partial immunity
can be estimated by analyzing the risk of infection by age
groups under the assumption that it would increase with age
because of longer exposure. The effect of age on the risk of
infection was adjusted for the confounding effects of forest
activity, bed net use, and socioeconomic level, which were
shown to be strong risk factors for malaria infections, to get
a better estimate of the independent effect of age.14 Thus,
the adjusted effect of age showed that the odds of infection
decreased with increased age. In persons ³ 20 years of age,
the odds of infection were significantly lower compared with
children less than five years of age. This age dependent risk
was also illustrated by the evolution the ratio sub-patent/
patent infections. Patent infections were more common in the
younger groups, and in persons ³ 20 years of age sub-patent
Table 2
Multivariate adjusted analysis for the risk of malaria infection by age
group (survey logistic regression models), central Vietnam*
Characteristic
No, positive/
no. tested AOR P 95% CI
All malaria infections†
Age groups, years
0–4 68/209 1
5–9 142/425 1.17 0.26 0.88–1.54
10–14 94/315 0.89 0.53 0.59–1.32
15–19 70/235 0.77 0.27 0.47–1.26
20–29 126/467 0.65 0.02 0.46–0.92
³ 30 171/652 0.65 0.03 0.45–0.96
Patent infections†‡
Age groups, years
0–4 47/68 1
5–9 79/142 0.52 0.13 0.22–1.24
10–14 55/94 0.5 0.08 0.23–1.09
15–19 40/70 0.38 0.09 0.12–1.18
20–29 49/126 0.18 0.001 0.08–0.44
³ 30 61/171 0.16 0.001 0.06–0.43
Gametocyte carriage†‡
Age groups, years
0–4 29/68 1
5–9 40/142 0.49 0.03 0.26–0.93
10–14 22/94 0.31 0.00 0.16–0.63
15–19 15/70 0.25 0.01 0.1–0.70
20–29 18/128 0.15 0.00 0.06–0.35
³ 30 20/171 0.12 0.00 0.06–0.24
Mixed infections†‡
Age groups, years
0–4 21/68 1
5–9 38/142 0.8 0.49 0.42–1.55
10–14 22/94 0.48 0.09 0.21–1.12
15–19 15/70 0.41 0.01 0.21–0.79
20–29 34/126 0.53 0.1 0.25–1.13
³ 30 34/171 0.34 0.02 0.14–0.80
Symptomatic infection†‡
Age groups, years
0–4 19/68 1
5–9 25/142 0.58 0.196 0.245–1.362
10–14 19/94 0.54 0.088 0.266–1.105
15–19 15/70 0.51 0.119 0.210–1.214
20–29 23/126 0.37 0.015 0.171–0.809
³ 30 23/171 0.26 0.003 0.111–0.594
*AOR = adjusted odds ratio; CI = confidence interval.
†Adjusted for forest work, socioeconomic level, and bed net use.
‡Among all infected persons.
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infections largely exceeded patent infections. This finding was
confirmed in the multivariate adjusted analysis where the odds
of patent infection was reduced by ³ 80% and the odds of
symptomatic infection was reduced by ³ 66.7% in infected
adults compared with infected children. A recent report by
Proietti and others showed similar results from an area of high
malaria endemicity in Uganda, where the proportion of sub-
patent P. falciparum infections changed from 20% in children
less than 15 years of age to approximately 50% in the older
age groups.18
With increasing age, the prevalence of gametocyte carriage
and mixed infections decreased markedly and their risks
were significantly decreased by 75% and 60%, respectively,
at the age of adolescence. The observed results of age depen-
dency likely indicate the progressive acquisition of immunity.
Other reports mentioning the age dependency of malaria
prevalence and symptomatic disease also attributed this phe-
nomenon to the acquisition of protective immunity.5,8,10,20
Two forms of immunity are likely to occur. One form is
anti-disease immunity, which is illustrated by numerous
asymptomatic infections even in young children and the sig-
nificantly lower risk of symptomatic infection (compared
with asymptomatic infection) in adults.20,21 The other form
is immunity against the parasites, which develops more
slowly, and results in lower prevalence with low densities
infections in the adult population. The partial development
of anti-parasite immunity might be responsible for lower risk
of symptomatic and patent infection by age. The reduction of
the risk for symptomatic and patent disease became signifi-
cant in adults and corresponds to cumulative exposure during
adult life when working in forest fields. In addition, as
observed in Indonesia, immunity to infections may develop
more rapidly in adults than in children and probably contrib-
utes to the lower risk of clinical malaria observed in individ-
uals ³ 20 years of age.22,23
Adults had lower gametocyte carriage, suggesting a lower
transmissibility to the vector. However, the gametocytes identi-
fied by microscopy are likely to represent only the tip of the
iceberg.24 In Kenya, gametocyte prevalence in children infected
with P. falciparum was approximately four times higher by PCR
Figure 2. Prevalence of gametocyte carriage and mixed malaria infections with mean parasite density (geometric mean) by age group, central
Vietnam. Mono = mono-infections.
Figure 3. Prevalence of symptomatic, asymptomatic and sub-patent malaria infections by age group, central Vietnam.
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compared with that determined bymicroscopy.25 The long dura-
tion of gametocytes carriage after infection (£ 55 days) and the
ability of sub-patent gametocyte infections to infect mosquitoes
makes the adult population a potent reservoir for sustaining
transmission.25,26 This suggestion is plausible if one considers
the behavior of the vector (exophilic and exophagic) and expo-
sure to mosquito bites of adults in forests, where these persons
can easily infect mosquitoes. The contribution of asymptomatic
and sub-patent infection to maintain malaria transmission
within this context should be further clarified. Sub-patent and
asymptomatic infections have been shown to be infective to
mosquitoes, although at lower rates than patent and symp-
tomatic infections, but because sub-patent and asymptomatic
infections are more prevalent and remain undetected longer,
their contribution might be substantial.9
If one considers that this is a cross-sectional study, the
evolution of asymptomatic or sub-patent infections towards
clinical malaria cannot be excluded because infected persons
were not followed-up and may have shown development of a
clinical attack after the survey. Nevertheless, asymptomatic
carriage, as indicated by its prevalence and by several reports
for the region, is probably a common occurrence.1,14,24
Therefore, the true parasite distribution of all five Plasmo-
dium species infecting humans in malaria-endemic regions of
Vietnam can be estimated only by conducting similar surveys
in other districts or provinces to which malaria is endemic.27
Such information will be essential for guiding and monitoring
future elimination efforts.
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